TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35550679

Group type: EXPERIMENTAL
Intervention: 2000 IU daily vitamin D3 for 12 weeks
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: 60,000 IU weekly for 3 weeks
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: 60,000 IU weekly for 6 weeks
Number of subjects: 132
Study: 35088736

Group type: EXPERIMENTAL
Intervention: Real 1-Hz inhibitory rTMS to the right pars triangularis (PTr) for ten consecutive weekdays
Number of subjects: 26

Group type: COMPARATOR
Intervention: Sham 1-Hz inhibitory rTMS to the right pars triangularis (PTr) for ten consecutive weekdays
Number of subjects: 26
Study: 32303594

Group type: EXPERIMENTAL
Intervention: Salut Programme (universal child health promotion intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Care-as-usual (control area)
Number of subjects: 0
Study: 35641136

Group type: EXPERIMENTAL
Intervention: CDS Hooks prompts suggesting the use of 6 medical calculators in a SMART on FHIR medical reference app
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no CDS Hooks prompts)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: CDS Hooks prompts
Number of subjects: 70
Study: 34444289

Group type: EXPERIMENTAL
Intervention: Amaranth oil
Number of subjects: 44

Group type: COMPARATOR
Intervention: Rapeseed oil
Number of subjects: 44
Study: 33303445

Group type: EXPERIMENTAL
Intervention: Web-based patient decision aid (PtDA) for GAD
Number of subjects: 124

Group type: COMPARATOR
Intervention: Fact sheet with general information on mental health
Number of subjects: 124
Study: 35403286

Group type: COMPARATOR
Intervention: PPOIT
Number of subjects: 62
Study: 35246232

Group type: EXPERIMENTAL
Intervention: Virtual focus group discussions
Number of subjects: 0
Study: 33972334

Group type: EXPERIMENTAL
Intervention: Perampanel (titrated to 6 mg daily over 4 weeks)
Number of subjects: 328

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Perampanel
Number of subjects: 328
Study: 32075641

Group type: EXPERIMENTAL
Intervention: Simulation by gaming (SG)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Traditional Teaching (TT)
Number of subjects: 146
Study: 35088717

Group type: EXPERIMENTAL
Intervention: Threshold tracked short-interval intracortical inhibition (TT-SICI)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Conventional short-interval intracortical inhibition (C-SICI)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: C-SICI
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: TT-SICI
Number of subjects: 20
Study: 34468987

Group type: EXPERIMENTAL
Intervention: Simulation training using modified working casts
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (didactic instructions only)
Number of subjects: 100
Study: 34050975

Group type: EXPERIMENTAL
Intervention: Visual pedagogy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mobile based application (Brush Up)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study: 32586348

Group type: EXPERIMENTAL
Intervention: Preoperative ropivacaine block group
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Postoperative ropivacaine block group
Number of subjects: 180

Group type: COMPARATOR
Intervention: Nonblocking control group
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 180
Study: 33724079

Group type: EXPERIMENTAL
Intervention: Genetically determined visceral adiposity (per 1 SD)
Number of subjects: 67
Study: 33067055

Group type: EXPERIMENTAL
Intervention: Higher levels of Ω‐6 fatty acids (AA, OA, AdA) at age 7 years
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Total Ω‐6 levels at age 16 years
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Total plasma Ω‐3 fatty acid levels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ω‐6/Ω‐3 ratio
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Genetic instruments of total Ω‐3 or Ω‐6 levels
Number of subjects: 0
Study: 32979642

Group type: EXPERIMENTAL
Intervention: Postextubation complications (overall, major, and minor)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Major complications
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Extubation failure
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Postextubation complications
Number of subjects: 240
Study: 35428359

Group type: EXPERIMENTAL
Intervention: Peer coach intervention (CARE RA curriculum with assistance from a peer coach, weekly calls for 5 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (CARE RA curriculum without assistance)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Peer coach intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 32032400

Group type: EXPERIMENTAL
Intervention: 100% autogenous bone (group AB)
Number of subjects: 8

Group type: COMPARATOR
Intervention: 50% deproteinized bovine bone matrix (DBBM)/50% autogenous bone (group BOAB)
Number of subjects: 8
Study: 35176844

Group type: EXPERIMENTAL
Intervention: Sinecatechins 10% ointment applied 3 times daily for 4 months after cryotherapy
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Sinecatechins 10% ointment
Number of subjects: 55
Study: 33895598

Group type: EXPERIMENTAL
Intervention: Welcome Basket peer support intervention (1–2 sessions pre-discharge and weekly for a month post-discharge)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Brief version of the Welcome Basket intervention (1 community session post-discharge)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 110
Study: 32607794

Group type: EXPERIMENTAL
Intervention: Postmenopausal women
Number of subjects: 81

Group type: COMPARATOR
Intervention: Premenopausal women
Number of subjects: 81
Study: 34448177

Group type: EXPERIMENTAL
Intervention: Educational program (4 sessions at weekly intervals)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Routine diabetic care
Number of subjects: 72
Study: 32693672

Group type: EXPERIMENTAL
Intervention: 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 37417644

Group type: EXPERIMENTAL
Intervention: HPE (plated)™ CALM Serum
Number of subjects: 18

Group type: COMPARATOR
Intervention: Standard of care (Stratacel silicone gel)
Number of subjects: 18
Study: 33413702

Group type: COMPARATOR
Intervention: Low RF (300 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Medium RF (600 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: High RF (900 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: All RF levels
Number of subjects: 8
Study: 33543226

Group type: EXPERIMENTAL
Intervention: Transverse T‐shaped coronectomy
Number of subjects: 120

Group type: COMPARATOR
Intervention: Longitudinal T‐shaped coronectomy
Number of subjects: 120
Study: 33962510

Group type: EXPERIMENTAL
Intervention: Sheetali pranayama for 5 min (5 cycles)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sheetali pranayama
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal breathing (control group)
Number of subjects: 60
Study: 34288973

Group type: EXPERIMENTAL
Intervention: Botanical combination (soy isoflavone extract 100mg, Aframomum melegueta seed dry extract 50mg, Punica granatum skin dry extract 100mg)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Botanical combination
Number of subjects: 57
Study: 32449530

Group type: EXPERIMENTAL
Intervention: Cranberry capsules (twice daily for 6 weeks)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Placebo (twice daily for 6 weeks)
Number of subjects: 210
Study: 34093436

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (26 weeks of supervised treadmill training)
Number of subjects: 23
Study: 33015869

Group type: EXPERIMENTAL
Intervention: 100 mg saffron/daily
Number of subjects: 80

Group type: COMPARATOR
Intervention: 100 mg maltodextrin/daily
Number of subjects: 80
Study: 32709757

Group type: EXPERIMENTAL
Intervention: Intervention group (de novo uveitis patients receiving standard care)
Number of subjects: 466
Study: 32517391

Group type: EXPERIMENTAL
Intervention: US-guided injection
Number of subjects: 62

Group type: COMPARATOR
Intervention: TENS therapy
Number of subjects: 62

Group type: COMPARATOR
Intervention: Sham TENS therapy
Number of subjects: 62
Study: 35777699

Group type: EXPERIMENTAL
Intervention: Intervention (text message vaping cessation)
Number of subjects: 1829

Group type: COMPARATOR
Intervention: Control
Number of subjects: 1829

Group type: EXPERIMENTAL
Intervention: Intervention
Number of subjects: 1829
Study: 33624044

Group type: EXPERIMENTAL
Intervention: Computerized decision support (CDS) system used during a randomly assigned 4-month period
Number of subjects: 2258

Group type: COMPARATOR
Intervention: Control group (no CDS used)
Number of subjects: 2258

Group type: EXPERIMENTAL
Intervention: CDS system
Number of subjects: 2258
Study: 32418680

Group type: EXPERIMENTAL
Intervention: Nutritional education program for four weeks
Number of subjects: 94
Study: 35199165

Group type: EXPERIMENTAL
Intervention: gD‐2 HSV vaccine adjuvanted with ASO4
Number of subjects: 8323

Group type: EXPERIMENTAL
Intervention: Neutralizing antibodies to HSV-1
Number of subjects: 8323

Group type: EXPERIMENTAL
Intervention: Neutralizing antibodies to HSV-2
Number of subjects: 8323
Study: 34919618

Group type: EXPERIMENTAL
Intervention: Extrashort (4-mm) implants
Number of subjects: 25

Group type: COMPARATOR
Intervention: Conventional (≥ 8-mm) implants
Number of subjects: 25
Study: 32418204

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35869682

Group type: EXPERIMENTAL
Intervention: TCI started with TBC set at 2.2 μg/ml
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: TCI started with TBC set at 2.6 μg/ml
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: TCI started with TBC set at 3.0 μg/ml
Number of subjects: 45
Study: 34503548

Group type: EXPERIMENTAL
Intervention: Minimally invasive distal pancreatectomy (MIDP)
Number of subjects: 258

Group type: COMPARATOR
Intervention: Open distal pancreatectomy (ODP)
Number of subjects: 258
Study: 32657920

Group type: EXPERIMENTAL
Intervention: Silicone-banded sleeve gastrectomy (BSG)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Nonbanded sleeve gastrectomy (SG)
Number of subjects: 94
Study: 33430924

Group type: EXPERIMENTAL
Intervention: BIO101 (20-hydroxyecdysone) 350 mg b.i.d.
Number of subjects: 465

Group type: COMPARATOR
Intervention: Placebo 350 mg b.i.d.
Number of subjects: 465
Study: 32918767

Group type: EXPERIMENTAL
Intervention: 25(OH)D
Number of subjects: 326409
Study: 32394777

Group type: EXPERIMENTAL
Intervention: CARET+CTI
Number of subjects: 131

Group type: COMPARATOR
Intervention: Sham CARET+CTI
Number of subjects: 131
Study: 35729592

Group type: EXPERIMENTAL
Intervention: New form of care with structured cooperation between medical geneticists and oncologists, case management, and telemedical genetic counseling.
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Routine care without structured cooperation or telemedical genetic counseling.
Number of subjects: 2000
Study: 32665120

Group type: EXPERIMENTAL
Intervention: Polished zirconia (PZ) crowns
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Glazed zirconia (GZ) crowns
Number of subjects: 14

Group type: COMPARATOR
Intervention: Natural enamel opposing natural enamel (NE-M)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Natural enamel opposing polished zirconia crowns (NE-PZ-M)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Natural enamel opposing glazed zirconia crowns (NE-GZ-M)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Natural enamel opposing polished zirconia crowns (NE-PZ-PM)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Natural enamel opposing glazed zirconia crowns (NE-GZ-PM)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Natural enamel opposing natural enamel (NE-PM)
Number of subjects: 14
Study: 33266318

Group type: EXPERIMENTAL
Intervention: EPA/DHA supplementation
Number of subjects: 0
Study: 34417112

Group type: EXPERIMENTAL
Intervention: CheReCunJin decoction only
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: CheReCunJin decoction combined with hydroxychloroquine
Number of subjects: 70
Study: 34247392

Group type: EXPERIMENTAL
Intervention: Dopaminergic precursor
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Dopaminergic antagonist
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 35615945

Group type: EXPERIMENTAL
Intervention: Patient photographs during simulated handoffs
Number of subjects: 40

Group type: COMPARATOR
Intervention: Simulated handoffs without photographs
Number of subjects: 40
Study: 33736678

Group type: EXPERIMENTAL
Intervention: Hand and foot acupuncture with twelve needles
Number of subjects: 208

Group type: COMPARATOR
Intervention: Routine acupuncture
Number of subjects: 208
Study: 32693322

Group type: EXPERIMENTAL
Intervention: Refutation message
Number of subjects: 1591

Group type: EXPERIMENTAL
Intervention: Sympathetic + factual message
Number of subjects: 1591

Group type: EXPERIMENTAL
Intervention: Sympathetic + factual + refutation message
Number of subjects: 1591

Group type: COMPARATOR
Intervention: Basic description of DCR
Number of subjects: 1591

Group type: EXPERIMENTAL
Intervention: Factual message alone
Number of subjects: 1591

Group type: EXPERIMENTAL
Intervention: Sympathetic message alone
Number of subjects: 1591
Study: 35422003

Group type: EXPERIMENTAL
Intervention: Peer-supported instant messaging service (IMS) intervention in addition to standard diabetes therapy for 7 months
Number of subjects: 205

Group type: COMPARATOR
Intervention: Standard diabetes therapy
Number of subjects: 205
Study: 33827843

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study: 32234462

Group type: EXPERIMENTAL
Intervention: Evolocumab 420 mg monthly
Number of subjects: 464

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 464
Study: 35272093

Group type: EXPERIMENTAL
Intervention: Early gestational diabetes diagnosed at <20 weeks gestation
Number of subjects: 119

Group type: COMPARATOR
Intervention: Gestational diabetes diagnosed by routine screening at 24-28 weeks gestation
Number of subjects: 119
Study: 33762244

Group type: EXPERIMENTAL
Intervention: Active rTMS + MCE
Number of subjects: 140

Group type: COMPARATOR
Intervention: Sham rTMS + MCE
Number of subjects: 140

Group type: COMPARATOR
Intervention: Active rTMS
Number of subjects: 140

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 140
Study: 33060086

Group type: EXPERIMENTAL
Intervention: It Takes Two intervention
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (HIV prevention information only)
Number of subjects: 100
Study: 35950781

Group type: EXPERIMENTAL
Intervention: Midodrine (10-mg tablets)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Midodrine
Number of subjects: 67
Study: 34050738

Group type: EXPERIMENTAL
Intervention: Higher platelet number PRP injections
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Lower platelet number PRP injections
Number of subjects: 8

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 8
Study: 32928216

Group type: EXPERIMENTAL
Intervention: Zinc sulfate (220 mg/d)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (lactose)
Number of subjects: 80
Study: 36163948

Group type: EXPERIMENTAL
Intervention: pegcetacoplan (1,080 mg subcutaneously twice weekly)
Number of subjects: 80

Group type: COMPARATOR
Intervention: eculizumab
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: pegcetacoplan
Number of subjects: 80
Study: 34712981

Group type: EXPERIMENTAL
Intervention: Bone Marrow Aspirate (BMA) injection
Number of subjects: 22

Group type: COMPARATOR
Intervention: Cortisone injection
Number of subjects: 22

Group type: COMPARATOR
Intervention: Comparison between BMA and Cortisone
Number of subjects: 22
Study: 36057629

Group type: COMPARATOR
Intervention: Daily supplementation with 250 ml fruit smoothie including a variety of fruits (apple, pineapple, mango, bananas, orange, blueberries, passion fruit, coconut, lime, blackcurrant) for 16 weeks.
Number of subjects: 302

Group type: COMPARATOR
Intervention: Standard treatment without added supplementation.
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Daily supplementation with 250 ml fruit smoothie.
Number of subjects: 302
Study: 32532831

Group type: EXPERIMENTAL
Intervention: UGT2B10 genetic score of 2
Number of subjects: 916

Group type: COMPARATOR
Intervention: UGT2B10 genetic score of 0
Number of subjects: 916

Group type: EXPERIMENTAL
Intervention: CYP2A6 activity ratio increase of 0.1
Number of subjects: 916

Group type: EXPERIMENTAL
Intervention: UGT2B10 genotype adjustment
Number of subjects: 916
Study: 35525396

Group type: EXPERIMENTAL
Intervention: Diet+Soccer (DS)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Diet+Running (DR)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Diet (D)
Number of subjects: 39
Study: 33771279

Group type: EXPERIMENTAL
Intervention: Integrated exposure therapy (COPE; Back et al., 2015)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Integrated coping skills therapy (Seeking Safety; Najavits, 2002)
Number of subjects: 119
Study: 32673060

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (800 mg once, followed by 600 mg in 6 to 8 hours, then 600 mg daily for 4 more days)
Number of subjects: 491

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Number of subjects: 491
Study: 36400822

Group type: EXPERIMENTAL
Intervention: Grain production systems with species diversification
Number of subjects: 0

Group type: COMPARATOR
Intervention: Corn-soybean rotation without species diversification
Number of subjects: 0
Study: 34522910

Group type: EXPERIMENTAL
Intervention: Computerised cognitive remediation programme (brain games) for 8 weeks
Number of subjects: 372

Group type: COMPARATOR
Intervention: Low complexity computer games and health education classes (control group)
Number of subjects: 372
Study: 32011032

Group type: EXPERIMENTAL
Intervention: Connective Tissue Graft (CTG)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Guided Bone Regeneration (GBR)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 42
Study: 35189397

Group type: EXPERIMENTAL
Intervention: FTB‐Cath (femoral triangle catheter)
Number of subjects: 44

Group type: COMPARATOR
Intervention: F‐Cath (femoral nerve block)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: FTB‐Cath
Number of subjects: 44

Group type: COMPARATOR
Intervention: F‐Cath
Number of subjects: 44
Study: 34684356

Group type: EXPERIMENTAL
Intervention: Two enriched eggs per day for 4 months
Number of subjects: 99

Group type: COMPARATOR
Intervention: Two standard eggs per day for 4 months
Number of subjects: 99
Study: 33569732

Group type: EXPERIMENTAL
Intervention: Se‐NP (1 mg/kg diet)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Zn‐NP (10 mg/kg diet)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Se/Zn‐NP (1 mg/kg Se‐NP and 10 mg/kg Zn‐NP)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Se/Zn‐NP
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Se‐NP, Zn‐NP, Se/Zn‐NP
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Se‐NP, Zn‐NP
Number of subjects: 180

Group type: COMPARATOR
Intervention: CG (0 Se‐NP and Zn‐NP)
Number of subjects: 180
Study: 32114326

Group type: EXPERIMENTAL
Intervention: Updated Nutrition Facts Label (NFL)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Information intervention about added sugars
Number of subjects: 0
Study: 33666125

Group type: EXPERIMENTAL
Intervention: OsseoSpeed® TX (test)
Number of subjects: 92

Group type: COMPARATOR
Intervention: OsseoSpeed® (control)
Number of subjects: 92
Study: 34265008

Group type: EXPERIMENTAL
Intervention: Not working (employment status)
Number of subjects: 2609

Group type: EXPERIMENTAL
Intervention: Not living with spouse (living status)
Number of subjects: 2609

Group type: COMPARATOR
Intervention: Educational attainment
Number of subjects: 2609

Group type: COMPARATOR
Intervention: Equivalent household expenditure (EHE)
Number of subjects: 2609
Study: 36053813

Group type: EXPERIMENTAL
Intervention: One session of RT-CGM
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Two sessions of RT-CGM with a 3-month interval
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 61
Study: 34449461

Group type: EXPERIMENTAL
Intervention: Rational emotive occupational health coaching for 12 weeks
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 63
Study: 32172334

Group type: EXPERIMENTAL
Intervention: Cetuximab (cet)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Resection of metastases
Number of subjects: 270

Group type: COMPARATOR
Intervention: Bevacizumab (bev)
Number of subjects: 270
Study: 35838535

Group type: EXPERIMENTAL
Intervention: Adrenaline + lidocaine detection group (AD group)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Cotton bud detection group (CD group)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 300
Study: 34314737

Group type: EXPERIMENTAL
Intervention: Border closure
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Quarantine of travelers
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Screening at departure and/or arrival
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Combination of public health measures
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Public support for travel restrictions
Number of subjects: 69
Study: 33017417

Group type: EXPERIMENTAL
Intervention: No scarring at baseline
Number of subjects: 1496

Group type: EXPERIMENTAL
Intervention: Scarring at baseline
Number of subjects: 1496
Study: 36442220

Group type: EXPERIMENTAL
Intervention: Individual implantation (group 1)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Randomized implantation (group 2)
Number of subjects: 50
Study: 32971307

Group type: EXPERIMENTAL
Intervention: Gut microbiota features (specifically 25 bacteria features including 9 orders and 16 families) analyzed in the discovery sample.
Number of subjects: 426824

Group type: EXPERIMENTAL
Intervention: Clostridiales and Lachnospiraceae (child taxon of Clostridiales)
Number of subjects: 426824
Study: 33052762

Group type: EXPERIMENTAL
Intervention: Mindfulness-Informed Intervention (MII) consisting of mindfulness training with cognitive, behavioral, and psychoeducational components, delivered in four 2-hour sessions weekly
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Mindfulness-Informed Intervention (MII)
Number of subjects: 56